Page last updated: 2024-08-24

rolofylline and Tauopathies

rolofylline has been researched along with Tauopathies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anglada-Huguet, M; Dennissen, FJ; Mandelkow, E; Mandelkow, EM; Sydow, A	1

Other Studies

1 other study(ies) available for rolofylline and Tauopathies

Article	Year
Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau ΔK280. Proceedings of the National Academy of Sciences of the United States of America, 2016, 10-11, Volume: 113, Issue:41 Topics: Adenosine A1 Receptor Antagonists; Adenosine Triphosphate; Animals; Axons; Dendritic Spines; Disease Models, Animal; Fluorescent Antibody Technique; Gene Expression; Hippocampus; Humans; Memory, Long-Term; Mice; Mice, Transgenic; Mitochondria; Neurons; Phosphorylation; Protein Aggregates; Protein Aggregation, Pathological; Sequence Deletion; Synaptic Transmission; tau Proteins; Tauopathies; Xanthines	2016

Article

Year

Adenosine A1 receptor antagonist rolofylline alleviates axonopathy caused by human Tau ΔK280.

Proceedings of the National Academy of Sciences of the United States of America, 2016, 10-11, Volume: 113, Issue:41

Topics: Adenosine A1 Receptor Antagonists; Adenosine Triphosphate; Animals; Axons; Dendritic Spines; Disease Models, Animal; Fluorescent Antibody Technique; Gene Expression; Hippocampus; Humans; Memory, Long-Term; Mice; Mice, Transgenic; Mitochondria; Neurons; Phosphorylation; Protein Aggregates; Protein Aggregation, Pathological; Sequence Deletion; Synaptic Transmission; tau Proteins; Tauopathies; Xanthines

2016